2026 NPPES data Hematology & Oncology Physician NPI 1073693339 MD
Verify on CMS →

RAMMURTI KAMBLE, MD

Hematology & Oncology Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
944
Medicare Part D claims · 87 beneficiaries · Hematology & Oncology Physician avg: 847
MIPS score
91.3432/100
▲ 8 pts above national avg 83.1 · [object Object]

What the federal data shows

RAMMURTI KAMBLE, MD reported a CMS MIPS final score of 91.3432/100 — above the 83.1 national average — and filed 944 Medicare Part D claims in 2023.

91.3432/100
MIPS score · +8 vs avg
944
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RAMMURTI KAMBLE, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RAMMURTI KAMBLE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RAMMURTI KAMBLE, MD?

High performer (top quartile)

NPI registry status

Active

Issued 10/17/2006

NPI 1073693339

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

944 11% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

91.3432/100 8.243200000000002% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers

Hematology & Oncology Physician share within Texas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Texas

Medicare quality performance — MIPS

RAMMURTI KAMBLE, MD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
91.3432/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 91.3432/100 vs national avg 83.1

0%100%National avg83%91.3%
MIPS final score (Hematology & Oncology Physician) — 91.3432/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RAMMURTI KAMBLE, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 6565 FANNIN ST, HOUSTON, TX, 77030, with a listed phone of (713) 441-1450. NPI 1073693339 was issued on 10/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KAMBLE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 944 prescription claims written by this provider, covering 87 Medicare beneficiaries and totaling roughly $727K in drug spend, with an opioid prescribing rate of 5.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.3432/100 for the 2023 performance year (Quality 81.6474), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

6565 FANNIN ST
HOUSTON, TX 77030

Provider Details

NPI 1073693339
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 10/17/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.3432
Final Score
Avg: 83.1
81.6474
Quality
89.1302
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where RAMMURTI KAMBLE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BAYLOR COLLEGE OF MEDICINE
HOUSTON, TX
TEXAS ONCOLOGY PA
WEBSTER, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to RAMMURTI KAMBLE, MD. To verify RAMMURTI KAMBLE, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

944
Total Claims
$727K
Total Drug Cost
87
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,802
Total Day Supply
50,882
Generic Drug Cost
$414K
Opioid Claims
47 (5.0% rate)
Antibiotic Claims
76

Patient Demographics

Average Patient Age
69.0 years
Avg HCC Risk Score
3.97
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RAMMURTI KAMBLE, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Acyclovir
62
Potassium Chloride
43
Valacyclovir
Valacyclovir Hcl
39
Levofloxacin
37
Ursodiol
30
Fluconazole
29
Gabapentin
29
Montelukast Sodium
29
Ondansetron Hcl
25
Tamsulosin Hcl
24

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How RAMMURTI KAMBLE, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

RAMMURTI KAMBLE, MD's 944 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as KAMBLE.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RAMMURTI KAMBLE, MD's specialty?
RAMMURTI KAMBLE, MD specializes in Hematology & Oncology Physician and practices in HOUSTON, Texas. Credentials: MD.
How much does RAMMURTI KAMBLE, MD prescribe under Medicare Part D?
In 2023, RAMMURTI KAMBLE, MD wrote 944 Medicare Part D claims totaling $727K in drug costs for 87 beneficiaries.
What is RAMMURTI KAMBLE, MD's Medicare quality score?
RAMMURTI KAMBLE, MD has a CMS MIPS Final Score of 91.3432/100 (Quality: 81.6474). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RAMMURTI KAMBLE, MD located?
RAMMURTI KAMBLE, MD is located at 6565 FANNIN ST, HOUSTON, TX, 77030. Phone: (713) 441-1450.
What is RAMMURTI KAMBLE, MD's NPI number?
RAMMURTI KAMBLE, MD's National Provider Identifier (NPI) is 1073693339, issued on 10/17/2006.
Does RAMMURTI KAMBLE, MD prescribe opioids?
Yes, RAMMURTI KAMBLE, MD had 47 opioid claims in 2023 with an opioid prescribing rate of 5.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does RAMMURTI KAMBLE, MD prescribe most often?
Based on 2023 Medicare Part D data, RAMMURTI KAMBLE, MD's most frequently prescribed drugs include Acyclovir, Potassium Chloride, Valacyclovir. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RAMMURTI KAMBLE, MD accept Medicare?
RAMMURTI KAMBLE, MD appears in CMS Medicare data with 944 Part D claims and 87 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RAMMURTI KAMBLE, MD's credentials?
RAMMURTI KAMBLE, MD's NPI is 1073693339 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology